FULGENT GENETICS, INC. Interest Expense Nonoperating
FULGENT GENETICS, INC. (FLGT) reported Interest Expense Nonoperating of $59.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseNonoperating · last filed 2026-07-30
- FULGENT GENETICS, INC. interest expense nonoperating for the quarter ending 2026-06-30 was $59.00K, a 247.06% increase year-over-year.
- FULGENT GENETICS, INC. interest expense nonoperating for the quarter ending 2026-03-31 was $17.00K, a 21.43% increase year-over-year.
- FULGENT GENETICS, INC. interest expense nonoperating for the quarter ending 2025-12-31 was $16.00K, a 60.00% decline year-over-year.
- FULGENT GENETICS, INC. interest expense nonoperating for the quarter ending 2025-09-30 was $28.00K, a 100.00% increase year-over-year.
- FULGENT GENETICS, INC. interest expense nonoperating for fiscal 2025 was $75.00K.
- FULGENT GENETICS, INC. interest expense nonoperating for fiscal 2024 was -$170.00K, a 134.84% decline from fiscal 2023.
- FULGENT GENETICS, INC. interest expense nonoperating for fiscal 2023 was $488.00K, a 51.83% decline from fiscal 2022.
- FULGENT GENETICS, INC. interest expense nonoperating for fiscal 2022 was $1.01M.
| Period end | Interest Expense Nonoperating 3 month | Interest Expense Nonoperating 6 month | Interest Expense Nonoperating 9 month | Interest Expense Nonoperating 12 month |
|---|---|---|---|---|
| 2026-06-30 | $59.00K 10-Q · filed 2026-07-30 | $76.00K 10-Q · filed 2026-07-30 | $92.00K derived: sum of 3 quarters · filed 2026-07-30 | $120.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $17.00K 10-Q · filed 2026-05-01 | $33.00K derived: sum of 2 quarters · filed 2026-05-01 | $61.00K derived: sum of 3 quarters · filed 2026-05-01 | $78.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $44.00K derived: sum of 2 quarters · filed 2026-02-27 | $61.00K derived: sum of 3 quarters · filed 2026-07-30 | $75.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $28.00K 10-Q · filed 2025-11-07 | $45.00K derived: sum of 2 quarters · filed 2026-07-30 | $59.00K 10-Q · filed 2025-11-07 | $99.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $17.00K 10-Q · filed 2026-07-30 | $31.00K 10-Q · filed 2026-07-30 | $71.00K derived: sum of 3 quarters · filed 2026-07-30 | $85.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $14.00K 10-Q · filed 2026-05-01 | $54.00K derived: sum of 2 quarters · filed 2026-05-01 | $68.00K derived: sum of 3 quarters · filed 2026-05-01 | $93.00K derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $54.00K derived: sum of 2 quarters · filed 2026-02-27 | $79.00K derived: sum of 3 quarters · filed 2026-02-27 | -$170.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $14.00K 10-Q · filed 2025-11-07 | $39.00K derived: sum of 2 quarters · filed 2025-11-07 | -$210.00K 10-Q · filed 2025-11-07 | -$347.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $25.00K 10-Q · filed 2025-08-01 | -$224.00K 10-Q · filed 2025-08-01 | -$361.00K derived: sum of 3 quarters · filed 2026-02-27 | -$291.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$249.00K 10-Q · filed 2025-05-02 | -$386.00K derived: sum of 2 quarters · filed 2026-02-27 | -$316.00K derived: sum of 3 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$137.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$67.00K derived: sum of 2 quarters · filed 2026-02-27 | $488.00K 10-K · filed 2026-02-27 | |
| 2023-09-30 | $70.00K 10-Q · filed 2024-11-08 | $625.00K 10-Q · filed 2024-11-08 | ||
| 2022-12-31 | $1.01M 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |